MJ Biotech, Inc. Signed Letter of Intent to Acquire a Producing Marijuana Farm Located in Oregon

Cheyenne, WY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MJTV MJ Biotech, Inc. (f/k/a Michael James Enterprises, Inc.) announces that MJ Biotech, Inc. has executed a Letter Of Intent to purchase a producing Marijuana Farm facility located in Oregon situated approximately 30 miles north of Portland. Once acquired, the plan will be to increase the current production levels of Organic Medical Marijuana products for distribution in Oregon and eventually produce a high-quality CBD. 

MJ Biotech will soon begin production of CBD Coffee Powdered Creamers. MJ Biotech is also in development of a LIQUID form of CBD Coffee Creamers, which is unique product within the market place.

These products can be seen at the corporate website www.mjbiotech.us and also at its subsidiaries website www.mjsyndicated.com.   These new products are being sold through clinics in Florida and online at https://mjbiotech.myshopify.com.

About Us

With a mission and commitment to promote health and wellness, MJ BIOTECH, INC., is diligently seeking new Commercial opportunities and relationships.  These exciting new avenues range from the Medical Cannabis sector to healthy lifestyle products. 

It is the MJ BIOTECH, INC., goal to not only promote and provide products for the public good, but to always remember our prime directive is that of enhancing Shareholder value. 

We believe we can achieve both of these objectives by promoting positive lifestyle choices in the Commercial relationships that we create, foster and support. 

Safe Harbor Statement

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as "would," "may," "will," "expects," and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this release and involve risks and uncertainties that could cause actual results to differ materially from current expectations. We assume no obligation to update or revise any forward-looking statement, whether because of new information, future events or any other reason.

For additional information please contact via email at info@mjbiotech.us